Adcock Ingram Holdings Limited (JSE:AIP)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc | Market Cap | 10.98B +7.2% |
| Revenue (ttm) | 9.76B +1.2% |
| Net Income | 858.51M +5.5% |
| EPS | 5.71 +8.5% |
| Shares Out | 146.76M |
| PE Ratio | 13.10 |
| Forward PE | 12.51 |
| Dividend | 2.80 (3.74%) |
| Ex-Dividend Date | Sep 17, 2025 |
| Volume | 719,869 |
| Open | 7,470.00 |
| Previous Close | 7,470.00 |
| Day's Range | 7,470.00 - 7,489.00 |
| 52-Week Range | 4,301.00 - 7,489.00 |
| Beta | 0.50 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 20, 2025 |
About Adcock Ingram Holdings
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four segments: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company provides various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription... [Read more]
Financial Performance
In 2025, Adcock Ingram Holdings's revenue was 9.76 billion, an increase of 1.22% compared to the previous year's 9.64 billion. Earnings were 858.51 million, an increase of 5.47%.
Financial StatementsNews
NATCO Pharma approves Rs 1,069 crore investment to raise Adcock Ingram stake to 49%
NATCO Pharma has approved the acquisition of an additional stake in South Africa-based Adcock Ingram Holdings Proprietary Limited, increasing its shareholding from 35.75% to 49%. The transaction, valu...
Pharma expansion: Natco to acquire major stake in South Africa’s Adcock Ingram, firm to go private
Indian firm Natco Pharma is set to acquire substantial stakes in South African pharmaceutical company Adcock Ingram. This deal, valued at R4.2 billion, will transition Adcock Ingram into a privately h...
Natco Pharma moves closer to Adcock Ingram acquisition with shareholder vote set for October
Natco Pharma Limited has announced that, through its wholly owned South African subsidiary, it has issued a combined circular with Adcock Ingram Holdings Limited to convene a general meeting of shareh...
NATCO Pharma offers to acquire 35.75% stake in South Africa’s Adcock Ingram for Rs 2,000 crore
NATCO Pharma Limited has taken a bold step towards strengthening its international presence by offering to buy out minority shareholders of South Africa-based Adcock Ingram Holdings. The Hyderabad-bas...
Natco Pharma plans to acquire majority stake in South Africa’s Adcock Holdings: Report
According to sources cited by CNBC Awaaz, Natco Pharma is planning to acquire a majority stake in Adcock Holdings, a South Africa-based pharmaceutical company. The Hyderabad-headquartered drug maker i...
Adcock Ingram's alliance with Medline set to transform South African healthcare
Medline is a manufacturer and distributor of medical supplies and services, with annual global sales in excess of $23bln